Dallas, TX, United States of America

Christopher Howard

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Phase Pharmaceuticals LLC, Drs Sensors & Targeting Systems, Inc.. Active years: 2009-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Howard. Retrieved from https://idiyas.com/inventor/christopher-howard-wzejpzv3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Christopher Howard

Introduction

Christopher Howard, an innovative inventor based in Dallas, TX, has made significant contributions to the field of pharmaceuticals with his inventive designs. With a total of three patents to his name, Howard has focused on creating solutions that address critical health challenges, particularly in the context of anaphylaxis and emergency medical situations.

Latest Patents

One of Christopher Howard's notable inventions is the sublingual epinephrine tablet. This breakthrough device offers a novel method for administering epinephrine to patients experiencing anaphylaxis. The tablets can also be used for concomitant therapy during cardiac events, treat hypoglycemia, and serve as prophylaxis for immunotherapy. Remarkably, Howard has two patents related to this innovative product, reflecting both the relevance and significance of his work in enhancing patient care during emergencies.

Career Highlights

Throughout his career, Christopher Howard has worked with leading companies in the pharmaceutical sector, including Phase Pharmaceuticals LLC and Drs Sensors & Targeting Systems, Inc. His experience in these organizations has allowed him to hone his skills and develop transformative healthcare solutions that improve patient outcomes.

Collaborations

In his professional journey, Howard has collaborated with skilled colleagues such as G Lynn Howard and Nicholas J Farina. These partnerships have provided fertile ground for creativity and innovation, contributing to the advancement of health-related technologies and therapies.

Conclusion

Christopher Howard exemplifies the spirit of innovation through his dedication to improving healthcare solutions. His work on sublingual epinephrine tablets not only highlights his inventiveness but also addresses urgent medical needs. As he continues to develop new ideas, the impact of his contributions will undoubtedly resonate in the medical community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…